CymitQuimica logo

CAS 331752-47-7

:

Cyclohexanecarboxamide,4-[(1R)-1-aminoethyl]-N-4-pyridinyl-, hydrochloride, hydrate (1:2:1), trans-

Description:
Cyclohexanecarboxamide, 4-[(1R)-1-aminoethyl]-N-4-pyridinyl-, hydrochloride, hydrate (1:2:1), trans- is a chemical compound characterized by its complex structure, which includes a cyclohexane ring, an amide functional group, and a pyridine moiety. This compound is typically encountered as a hydrochloride salt, indicating it is soluble in water and may exhibit different properties compared to its free base form. The presence of the aminoethyl group suggests potential biological activity, possibly interacting with various receptors or enzymes. The trans configuration indicates specific stereochemistry, which can influence the compound's pharmacological properties. As a hydrate, it contains water molecules in its crystalline structure, which can affect its stability and solubility. This compound may be of interest in medicinal chemistry and pharmacology, particularly for its potential therapeutic applications. However, detailed studies on its biological activity, toxicity, and pharmacokinetics would be necessary to fully understand its characteristics and potential uses.
Formula:C14H21N3O・2ClH・H2O
Synonyms:
  • Cyclohexanecarboxamide,4-[(1R)-1-aminoethyl]-N-4-pyridinyl-, dihydrochloride, monohydrate, trans-(9CI)
Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.
  • Ref: IN-DA00C9IU

    1mg
    To inquire
    100mg
    To inquire
  • Y-27632 HCl hydrate

    CAS:
    Y-27632 HCl hydrate is an orally effective, ATP-competitive ROCK1/ROCK2 inhibitor (Ki=220 nM/300 nM) that inhibits caspase-3 and suppresses stem cell apoptosis.
    Formula:C14H25Cl2N3O2
    Purity:99.98%
    Color and Shape:Solid
    Molecular weight:338.27

    Ref: TM-T69429

    1mg
    264.00€
    5mg
    650.00€
    10mg
    888.00€
    25mg
    1,369.00€
    50mg
    1,783.00€
  • Y-27632-d4 Dihydrochloride Hydrate

    Controlled Product
    CAS:

    Applications A labelled Rho kinase inhibitor (ROCK) for the treatment of ischemia-reperfusion disorders.
    References Hirose, M., et al.: J. Cell. Biol., 141, 1625 (1998), Maekawa, M., et al.: Science, 285, 895 (1999), Ye, X., et al.: Jpn. J. Pharmacol., 83, 161 (2000), Chitaley, et al.: Nat. Med., 7, 119 (2001), Watanabe, K., et al.: Nature Biotech., 25, 681 (2007),

    Formula:C14H21D4Cl2N3O2
    Color and Shape:Grey
    Molecular weight:342.3

    Ref: TR-Y100502

    1mg
    254.00€
    10mg
    1,711.00€